Table 2.
AMH + OA | AMH + HA | AMH + OA or HA | Two of (AMH/OA/HA) | ||||||
---|---|---|---|---|---|---|---|---|---|
PCOS | Non-PCOS | PCOS | Non-PCOS | PCOS | Non-PCOS | PCOS | Non-PCOS | ||
ROT | PCOS | 158 | 70 | 166 | 62 | 190 | 38 | 218 | 10 |
Non-PCOS | 1 | 377 | 1 | 377 | 0 | 378 | 0 | 378 | |
AES | PCOS | 132 | 63 | 161 | 34 | 160 | 35 | 188 | 7 |
Non-PCOS | 27 | 384 | 6 | 405 | 30 | 381 | 30 | 381 | |
NIH | PCOS | 131 | 33 | 137 | 27 | 136 | 28 | 164 | 0 |
Non-nCOS | 28 | 414 | 30 | 412 | 54 | 388 | 54 | 388 |
Distribution of patients before and after the re-evaluation process is depicted